229 related articles for article (PubMed ID: 31883420)
1. TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma.
Yamada Y; Kimura N; Takayama KI; Sato Y; Suzuki T; Azuma K; Fujimura T; Ikeda K; Kume H; Inoue S
Cancer Sci; 2020 Mar; 111(3):881-890. PubMed ID: 31883420
[TBL] [Abstract][Full Text] [Related]
2. TRIM44 facilitates ovarian cancer proliferation, migration, and invasion by inhibiting FRK.
Yu XZ; Yuan JL; Ye H; Yi K; Qie MR; Hou MM
Neoplasma; 2021 Jul; 68(4):751-759. PubMed ID: 34034495
[TBL] [Abstract][Full Text] [Related]
3. A novel prognostic factor TRIM44 promotes cell proliferation and migration, and inhibits apoptosis in testicular germ cell tumor.
Yamada Y; Takayama KI; Fujimura T; Ashikari D; Obinata D; Takahashi S; Ikeda K; Kakutani S; Urano T; Fukuhara H; Homma Y; Inoue S
Cancer Sci; 2017 Jan; 108(1):32-41. PubMed ID: 27754579
[TBL] [Abstract][Full Text] [Related]
4. The Novel Target of Colorectal Carcinoma: TRIM44 Regulates Cell Migration and Invasion via Activation of CXCR4/NF-κB Signaling.
Kou T; Sha D; Wang F; He T; He X
Cell Biochem Biophys; 2021 Mar; 79(1):113-121. PubMed ID: 33151473
[TBL] [Abstract][Full Text] [Related]
5. YTHDF1 promotes the proliferation, migration, and invasion of prostate cancer cells by regulating TRIM44.
Li W; Chen G; Feng Z; Zhu B; Zhou L; Zhang Y; Mai J; Jiang C; Zeng J
Genes Genomics; 2021 Dec; 43(12):1413-1421. PubMed ID: 34677810
[TBL] [Abstract][Full Text] [Related]
6. TRIM44 Is a Poor Prognostic Factor for Breast Cancer Patients as a Modulator of NF-κB Signaling.
Kawabata H; Azuma K; Ikeda K; Sugitani I; Kinowaki K; Fujii T; Osaki A; Saeki T; Horie-Inoue K; Inoue S
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885545
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of TRIM44 Inhibits the Proliferation and Invasion in Prostate Cancer Cells.
Tan Y; Yao H; Hu J; Liu L
Oncol Res; 2017 Sep; 25(8):1253-1259. PubMed ID: 28160462
[TBL] [Abstract][Full Text] [Related]
8. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer.
Yu Y; Li S; Sun J; Wang Y; Xie L; Guo Y; Li J; Han F
Genes Genomics; 2024 Jun; 46(6):689-699. PubMed ID: 38691326
[TBL] [Abstract][Full Text] [Related]
10. Tripartite Motif-Containing 44 is Involved in the Tumorigenesis of Laryngeal Squamous Cell Carcinoma, and its Expression is Downregulated by Nuciferine.
Li QH; Sui LP; Zhao YH; Chen BG; Li J; Ma ZH; Hu ZH; Tang YL; Guo YX
Tohoku J Exp Med; 2021 May; 254(1):17-23. PubMed ID: 34011804
[TBL] [Abstract][Full Text] [Related]
11. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
Wang J; Xu Y; Zhu L; Zou Y; Kong W; Dong B; Huang J; Chen Y; Xue W; Huang Y; Zhang J
J Cancer Res Clin Oncol; 2018 Jan; 144(1):39-52. PubMed ID: 28993942
[TBL] [Abstract][Full Text] [Related]
13. TRIM37 orchestrates renal cell carcinoma progression via histone H2A ubiquitination-dependent manner.
Miao C; Liang C; Li P; Liu B; Qin C; Yuan H; Liu Y; Zhu J; Cui Y; Xu A; Wang S; Su S; Li J; Shao P; Wang Z
J Exp Clin Cancer Res; 2021 Jun; 40(1):195. PubMed ID: 34130705
[TBL] [Abstract][Full Text] [Related]
14. ELFN1-AS1 accelerates the proliferation and migration of colorectal cancer via regulation of miR-4644/TRIM44 axis.
Lei R; Feng L; Hong D
Cancer Biomark; 2020; 27(4):433-443. PubMed ID: 31929141
[TBL] [Abstract][Full Text] [Related]
15. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of TRIM44 contributes to malignant outcome in gastric carcinoma.
Kashimoto K; Komatsu S; Ichikawa D; Arita T; Konishi H; Nagata H; Takeshita H; Nishimura Y; Hirajima S; Kawaguchi T; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Cancer Sci; 2012 Nov; 103(11):2021-6. PubMed ID: 22862969
[TBL] [Abstract][Full Text] [Related]
17. TRIM44 promotes human esophageal cancer progression via the AKT/mTOR pathway.
Xiong D; Jin C; Ye X; Qiu B; Jianjun X; Zhu S; Xiang L; Wu H; Yongbing W
Cancer Sci; 2018 Oct; 109(10):3080-3092. PubMed ID: 30098109
[TBL] [Abstract][Full Text] [Related]
18. TRIM44 is indispensable for glioma cell proliferation and cell cycle progression through AKT/p21/p27 signaling pathway.
Zhou X; Yang Y; Ma P; Wang N; Yang D; Tu Q; Sun B; Xiang T; Zhao X; Hou Z; Fang X
J Neurooncol; 2019 Nov; 145(2):211-222. PubMed ID: 31605296
[TBL] [Abstract][Full Text] [Related]
19. The clinical significance of UBE2C gene in progression of renal cell carcinoma.
Chen Z; Wang L
Eur J Histochem; 2021 Mar; 65(2):. PubMed ID: 33782624
[TBL] [Abstract][Full Text] [Related]
20. TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4.
Wei CY; Wang L; Zhu MX; Deng XY; Wang DH; Zhang SM; Ying JH; Yuan X; Wang Q; Xuan TF; He AQ; Qi FZ; Gu JY
J Exp Clin Cancer Res; 2019 Mar; 38(1):137. PubMed ID: 30922374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]